Clinical Trial Update: Remedial Mechanism of Simvastatin and Ursodeoxycholic Acid in Liver Cirrhosis: Crosstalk of Bile Secretion, Gut Microbiome, and Host Immune Response [NA]

View source ↗

Summary

A clinical trial at Chang Gung Memorial Hospital is evaluating the remedial effects of simvastatin and ursodeoxycholic acid in liver cirrhosis, examining bile s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)
• Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Liver Cirrhosis | NA | Status: ENROLLING_BY_INVITATION